Holen Sie sich die Stockscreener-App
72.41
1.01%
-0.77
Schlusskurs vom Vortag:
$73.18
Offen:
$72.85
24-Stunden-Volumen:
767.62K
Relative Volume:
0.36
Marktkapitalisierung:
$8.47M
Einnahmen:
$947.36M
Nettoeinkommen (Verlust:
$392.47M
KGV:
23.98
EPS:
3.02
Netto-Cashflow:
$392.71M
1W Leistung:
+1.16%
1M Leistung:
+25.48%
6M Leistung:
+22.47%
1J Leistung:
+12.45%
1-Tages-Spanne:
$72.07
$72.85
1-Wochen-Bereich:
$70.32
$74.07
52-Wochen-Spanne:
$42.01
$74.07
Halozyme Therapeutics Inc Stock (HALO) Company Profile
Firmenname
Halozyme Therapeutics Inc
Sektor
Branche
Telefon
(858) 794-8889
Adresse
12390 EL CAMINO REAL, SAN DIEGO, CA
Vergleichen Sie HALO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HALO
Halozyme Therapeutics Inc
|
72.43 | 8.53B | 947.36M | 392.47M | 392.71M | 3.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.20 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.30 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
701.88 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.17 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Halozyme Therapeutics Inc Stock (HALO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-05-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Herabstufung | Leerink Partners | Market Perform → Underperform |
| 2024-10-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-06-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-02-29 | Eingeleitet | TD Cowen | Outperform |
| 2023-07-24 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-03-27 | Fortgesetzt | Berenberg | Buy |
| 2023-03-16 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2022-12-21 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-14 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-17 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-21 | Bestätigt | The Benchmark Company | Buy |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-01 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-01-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Buy |
| 2019-11-05 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2018-10-19 | Fortgesetzt | Piper Jaffray | Neutral |
| 2018-05-11 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-16 | Bestätigt | Piper Jaffray | Overweight |
| 2017-01-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2015-12-04 | Eingeleitet | Wells Fargo | Outperform |
| 2015-11-18 | Eingeleitet | Citigroup | Buy |
| 2015-09-22 | Eingeleitet | Barclays | Overweight |
| 2015-06-22 | Bestätigt | JP Morgan | Overweight |
| 2015-03-03 | Bestätigt | UBS | Buy |
| 2015-02-18 | Bestätigt | MLV & Co | Buy |
| 2015-01-08 | Bestätigt | MLV & Co | Buy |
Alle ansehen
Halozyme Therapeutics Inc Aktie (HALO) Neueste Nachrichten
Can a trend reversal in Halozyme Therapeutics Inc. lead to recoveryJuly 2025 Price Swings & Verified Trade Idea Suggestions - Newser
Published on: 2025-08-28 09:55:17 - Newser
Biotech Leader Halozyme Lines Up Major Presentations at Wells Fargo, Morgan Stanley Healthcare Conferences - Stock Titan
Analyzing net buyer seller activity in Halozyme Therapeutics Inc.2025 Market Sentiment & AI Driven Stock Movement Reports - Newser
What’s next for Halozyme Therapeutics Inc. stock priceJuly 2025 Decliners & Advanced Technical Signal Analysis - Newser
Halozyme Therapeutics Inc. stock volume spike explainedWeekly Trend Report & Smart Swing Trading Alerts - Newser
Published on: 2025-08-28 04:09:42 - Newser
What moving averages say about Halozyme Therapeutics Inc.Trend Reversal & Safe Capital Allocation Plans - Newser
Will Halozyme Therapeutics Inc. outperform the marketWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - Newser
Halozyme Therapeutics stock reaches all-time high at 73.5 USD By Investing.com - Investing.com Canada
Applying Wyckoff theory to Halozyme Therapeutics Inc. stockJuly 2025 Levels & Real-Time Buy Signal Alerts - Newser
Analyzing drawdowns of Halozyme Therapeutics Inc. with statistical toolsStock Surge & Weekly Sector Rotation Insights - Newser
Real time breakdown of Halozyme Therapeutics Inc. stock performance2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser
Visual trend scoring systems applied to Halozyme Therapeutics Inc.Weekly Earnings Recap & Accurate Intraday Trading Signals - Newser
What to expect from Halozyme Therapeutics Inc. in the next 30 daysMarket Growth Report & Daily Market Momentum Tracking - Newser
Real time social sentiment graph for Halozyme Therapeutics Inc.Risk Management & Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-08-27 10:40:29 - Newser
Is Halozyme Therapeutics Inc. stock ready for a breakoutJuly 2025 Setups & Risk Managed Investment Signals - Newser
Is a relief rally coming for Halozyme Therapeutics Inc. holdersWeekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser
Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock - Yahoo Finance
Halozyme Therapeutics stock reaches all-time high at 73.5 USD - Investing.com
Real time pattern detection on Halozyme Therapeutics Inc. stockPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Trend analysis for Halozyme Therapeutics Inc. this weekJuly 2025 WrapUp & Accurate Trade Setup Notifications - Newser
Is New CMS Drug Pricing Guidance Changing the Long-Term Growth Outlook for Halozyme Therapeutics (HALO)? - Yahoo Finance
Quantitative breakdown of Halozyme Therapeutics Inc. recent move2025 Price Targets & Long-Term Capital Growth Strategies - Newser
What candlestick patterns are forming on Halozyme Therapeutics Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Using data models to predict Halozyme Therapeutics Inc. stock movementJuly 2025 Spike Watch & Weekly Top Performers Watchlists - Newser
Halozyme Therapeutics Inc. stock prediction for this weekProfit Target & Growth Focused Entry Point Reports - Newser
What makes Halozyme Therapeutics Inc. stock price move sharply getLinesFromResByArray error: size == 0 - 더경남뉴스
Smart tools for monitoring Halozyme Therapeutics Inc.’s price actionEarnings Overview Report & Low Drawdown Trading Techniques - Newser
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Halozyme Therapeutics Inc. recovery potential after sell offBear Alert & Safe Entry Point Identification - Newser
Forecasting Halozyme Therapeutics Inc. price range with options dataWeekly Trading Summary & Expert Verified Movement Alerts - Newser
Halozyme Therapeutics (HALO) Fell Despite Reporting Strong Earnings and Improved Guidance - Yahoo Finance
Halozyme’s Big Q2 Raises Guidance - San Diego Business Journal
Published on: 2025-08-25 05:01:34 - Newser
Real time social sentiment graph for Halozyme Therapeutics Inc2025 Sector Review & Fast Exit/Entry Strategy Plans - Newser
Visual analytics tools that track Halozyme Therapeutics Inc. performanceGDP Growth & Pattern Based Trade Signal System - Newser
Finanzdaten der Halozyme Therapeutics Inc-Aktie (HALO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Halozyme Therapeutics Inc-Aktie (HALO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Torley Helen | PRESIDENT AND CEO |
Aug 12 '25 |
Option Exercise |
8.11 |
20,000 |
162,200 |
753,719 |
| Torley Helen | PRESIDENT AND CEO |
Aug 13 '25 |
Option Exercise |
8.11 |
20,000 |
162,200 |
753,719 |
| Torley Helen | PRESIDENT AND CEO |
Aug 13 '25 |
Sale |
64.32 |
20,000 |
1,286,351 |
733,719 |
| Torley Helen | PRESIDENT AND CEO |
Aug 12 '25 |
Sale |
63.51 |
20,000 |
1,270,121 |
733,719 |
| Torley Helen | PRESIDENT AND CEO |
Aug 11 '25 |
Sale |
63.05 |
20,000 |
1,260,917 |
733,719 |
| Torley Helen | PRESIDENT AND CEO |
Jul 08 '25 |
Option Exercise |
8.11 |
20,000 |
162,200 |
753,719 |
| Torley Helen | PRESIDENT AND CEO |
Jul 09 '25 |
Option Exercise |
8.11 |
20,000 |
162,200 |
753,719 |
| Torley Helen | PRESIDENT AND CEO |
Jul 10 '25 |
Option Exercise |
8.11 |
20,000 |
162,200 |
753,719 |
| Torley Helen | PRESIDENT AND CEO |
Jul 10 '25 |
Sale |
57.43 |
20,000 |
1,148,618 |
733,719 |
| Torley Helen | PRESIDENT AND CEO |
Jul 09 '25 |
Sale |
56.43 |
20,000 |
1,128,655 |
733,719 |
1.41%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):